🔬 Their Lean Bioengineering™ method uses CRISPR and machine learning for efficient biomanufacturing.
🌱 This approach reduces environmental impact and improves the consistency of plant-based ingredients.
🤝 Inscripta is partnering with commercial brands to deliver high-quality, effective products rapidly.
Introduction:
Inscripta has announced its successful scale-up of biomanufacturing processes for an anti-aging skincare ingredient, marking a significant advancement in the field of commercial biomanufacturing, particularly for plant-based compounds.
- Inscripta’s Lean Bioengineering™ approach utilizes directed evolution, CRISPR+, and machine learning to enhance the scalability and cost-effectiveness of biomanufacturing.
- The company aims to overcome challenges associated with plant-based ingredient sourcing, including environmental concerns and supply chain inconsistencies.
- Commercial manufacturing efforts have begun, with Inscripta working alongside partners to provide high-quality, efficacious skincare ingredients.
- Inscripta’s GenoScaler™ technology played a crucial role in developing optimized microbial strains, demonstrating performance reliability across varying bioreactor scales.
- The initiative presents a broader opportunity for the bioeconomy to enhance sustainability and efficiency in various sectors beyond personal care.
Conclusion:
Inscripta’s advancements in scalable biomanufacturing could significantly impact the sustainability and consistency of skincare ingredients, supporting the drive towards greener practices in the industry. This initiative not only responds to current market demands but also sets a precedent for future innovations in biomanufacturing across multiple sectors.
